Mersana Therapeutics buy Citigroup Inc.
Start price
04.12.23
/
50%
€1.71
Target price
04.12.24
€4.61
Performance (%)
25.26%
End price
05.12.24
€2.14
Summary
This prediction ended on 05.12.24 with a price of €2.14. The prediction had a final performance of 25.26%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Mersana Therapeutics | - | - | - |
| iShares Core DAX® | -2,80 % | -1,40 % | -0,22 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % | 29,00 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % | 48,21 % |
| iShares S&P 500 | -3,41 % | 0,40 % | 20,28 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $5.00 price target on the stock, up previously from $1.00.
Ratings data for MRSN provided by MarketBeat
In the thread Trading Mersana Therapeutics
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Mersana Therapeutics
Mersana Therapeutics
Start price
Target price
Perf. (%)
€2.40
15.11.24
15.11.24
€4.74
15.11.25
15.11.25
-89.06%
16.11.25
16.11.25
Mersana Therapeutics
Start price
Target price
Perf. (%)
€1.34
27.08.24
27.08.24
€4.48
27.08.25
27.08.25
-84.11%
28.08.25
28.08.25